Camrosh reviews food supplement bioavailability evidence for the FSA
- Food Standards Agency
- Yorkshire and the Humber
- Open procedure, 1 bid
- 5 June 2026 to 31 March 2028
The Food Standards Agency (FSA) hired Camrosh Limited to carry out a systematic literature review on how well the body absorbs food supplements.
Manufacturers increasingly sell supplements in novel forms, from lipid-based carriers such as liposomes and nanoparticles to micronisation, that claim better absorption. Evidence for those claims is limited and uncertain. The Committee on Toxicity (COT) recommended in 2025 that such formulations be assessed case by case. It stressed that whether a person has eaten matters.
One bid was received. Technical quality carried 80% of the score and price 20%. Camrosh won in May 2026 with a £291,720 contract that runs to March 2028, with an optional three more months.
Contract ends March 2028
- What
- Evidence reviews and literature reviews
- Supplier
- Camrosh Limited
- Value
- £291,720
- How it was bought
- Open procedure
- 1 bid
- Dates and next
- Jun 2026 to Mar 2028
- Option to Jun 2028